{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Liu A"],"funding":["Agency for Healthcare Research and Quality","AHRQ HHS","Arnold Ventures"],"pagination":["qxae136"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11538962"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["2(11)"],"pubmed_abstract":["While many Medicare beneficiaries are enrolling in Medicare Advantage (MA), some beneficiaries may want to return to traditional Medicare and purchase Medigap, especially beneficiaries who have greater medical needs. Beyond minimal federal regulations, states impose additional regulations that impact Medigap affordability. Beneficiaries in some states have greater difficulty obtaining Medigap coverage because the states where they live allow Medigap insurers to experience rate the beneficiary, which can make Medigap insurance prohibitively expensive. We examined beneficiaries who received physician-administered drugs, which can be expensive and subject to high cost sharing, to see if disenrollment from MA for these beneficiaries was greater in states with Medigap consumer protection policy"],"journal":["Health affairs scholar"],"pubmed_title":["Medigap-guaranteed issue associated with Medicare Advantage disenrollment for beneficiaries administered a part B drug."],"pmcid":["PMC11538962"],"funding_grant_id":["146501","T32 HS000029"],"pubmed_authors":["Pittman D","Liu A","Anderson G","Xu J"],"additional_accession":[]},"is_claimable":false,"name":"Medigap-guaranteed issue associated with Medicare Advantage disenrollment for beneficiaries administered a part B drug.","description":"While many Medicare beneficiaries are enrolling in Medicare Advantage (MA), some beneficiaries may want to return to traditional Medicare and purchase Medigap, especially beneficiaries who have greater medical needs. Beyond minimal federal regulations, states impose additional regulations that impact Medigap affordability. Beneficiaries in some states have greater difficulty obtaining Medigap coverage because the states where they live allow Medigap insurers to experience rate the beneficiary, which can make Medigap insurance prohibitively expensive. We examined beneficiaries who received physician-administered drugs, which can be expensive and subject to high cost sharing, to see if disenrollment from MA for these beneficiaries was greater in states with Medigap consumer protection policy","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Nov","modification":"2026-04-07T20:19:07.219Z","creation":"2025-04-05T18:51:15.348Z"},"accession":"S-EPMC11538962","cross_references":{"pubmed":["39507509"],"doi":["10.1093/haschl/qxae136"]}}